Cargando…

137例单份非亲缘脐血造血干细胞移植患者的临床研究

OBJECTIVE: To evaluate relevant prognostic factors of unrelated single unit umbilical cord blood hematopoietic stem cell transplantation (sUCBT), and to explore the correlation between cryopreservation time of cord blood and cell viability and outcome of sUCBT. METHODS: Retrospective analysis of 137...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342165/
https://www.ncbi.nlm.nih.gov/pubmed/25778891
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.012
_version_ 1783555391787892736
collection PubMed
description OBJECTIVE: To evaluate relevant prognostic factors of unrelated single unit umbilical cord blood hematopoietic stem cell transplantation (sUCBT), and to explore the correlation between cryopreservation time of cord blood and cell viability and outcome of sUCBT. METHODS: Retrospective analysis of 137 patients undergoing sUCBT with cord blood provided by Shanghai Cord Blood Bank from Mar. 15, 2007 to Dec. 26, 2013 were performed in this study. The mean cryopreservation time of 137 units cord blood was 698 (96-1968) days, with mean cell viability of 87.4% after thawing. RESULTS: No statistical difference on cell viability, hematopoietic reconstitution, graft failure, acute graft versus host disease (GVHD) and overall survival (OS) was found between patients transfused with cord blood preserved below and above 2 years. The 5-year OS of patients transfused with cord blood preserved below and above 2 years were 55.6% and 67.9%, respectively (P=0.124). OS of the UCBT at 2011 and before, and after 2011 was 48.7% and 79.6%, respectively (P=0.001). Age above 16-year-old (RR=2.830,P= 0.027) and UCBT at 2011 and before (RR=0.203,P<0.001) were two risk factors of treatment related mortality. CONCLUSION: Outcome of sUCBT in China had significant improvement in recent 2 years. Cryopreservation time of cord blood had no statistical correlation to cell viability after thawing and clinical outcome.
format Online
Article
Text
id pubmed-7342165
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73421652020-07-16 137例单份非亲缘脐血造血干细胞移植患者的临床研究 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To evaluate relevant prognostic factors of unrelated single unit umbilical cord blood hematopoietic stem cell transplantation (sUCBT), and to explore the correlation between cryopreservation time of cord blood and cell viability and outcome of sUCBT. METHODS: Retrospective analysis of 137 patients undergoing sUCBT with cord blood provided by Shanghai Cord Blood Bank from Mar. 15, 2007 to Dec. 26, 2013 were performed in this study. The mean cryopreservation time of 137 units cord blood was 698 (96-1968) days, with mean cell viability of 87.4% after thawing. RESULTS: No statistical difference on cell viability, hematopoietic reconstitution, graft failure, acute graft versus host disease (GVHD) and overall survival (OS) was found between patients transfused with cord blood preserved below and above 2 years. The 5-year OS of patients transfused with cord blood preserved below and above 2 years were 55.6% and 67.9%, respectively (P=0.124). OS of the UCBT at 2011 and before, and after 2011 was 48.7% and 79.6%, respectively (P=0.001). Age above 16-year-old (RR=2.830,P= 0.027) and UCBT at 2011 and before (RR=0.203,P<0.001) were two risk factors of treatment related mortality. CONCLUSION: Outcome of sUCBT in China had significant improvement in recent 2 years. Cryopreservation time of cord blood had no statistical correlation to cell viability after thawing and clinical outcome. Editorial office of Chinese Journal of Hematology 2015-02 /pmc/articles/PMC7342165/ /pubmed/25778891 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.012 Text en 2015年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
137例单份非亲缘脐血造血干细胞移植患者的临床研究
title 137例单份非亲缘脐血造血干细胞移植患者的临床研究
title_full 137例单份非亲缘脐血造血干细胞移植患者的临床研究
title_fullStr 137例单份非亲缘脐血造血干细胞移植患者的临床研究
title_full_unstemmed 137例单份非亲缘脐血造血干细胞移植患者的临床研究
title_short 137例单份非亲缘脐血造血干细胞移植患者的临床研究
title_sort 137例单份非亲缘脐血造血干细胞移植患者的临床研究
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342165/
https://www.ncbi.nlm.nih.gov/pubmed/25778891
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.012
work_keys_str_mv AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū
AT 137lìdānfènfēiqīnyuánqíxuèzàoxuègànxìbāoyízhíhuànzhědelínchuángyánjiū